Surgicel Original

DEVICE4 trials

Sponsors

Baxter Healthcare Corporation, Ethicon, LLC, Corza Medical GmbH, Ethicon, Inc.

Conditions

Bleeding ActiveHemorrhageHemostasisHemostatic Techniques

Phase 3

A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery

RecruitingNCT06664775

Corza Medical GmbHHemorrhage

Start: 2025-04-02End: 2026-06-30Target: 116Updated: 2025-10-06

Unknown Phase

Effectiveness and Safety of CELSTAT for Hemostasis in Intraoperative Tissue Bleeding

CompletedNCT02640235

Baxter Healthcare CorporationBleeding Active

Start: 2016-02-24End: 2017-10-18Updated: 2020-08-03

The SURGICEL® Powder Mild or Moderate Parenchymal or Soft Tissue Intraoperative Bleeding (China Study)

CompletedNCT03783039

Ethicon, LLCHemorrhage

Start: 2019-01-15End: 2020-05-06Updated: 2021-07-08

A Study of ETHIZIA Versus SURGICEL Original in Controlling Soft Tissue Bleeding During Open Surgery

RecruitingNCT06664788

Ethicon, Inc.Hemostasis, Hemostatic Techniques

Start: 2025-04-16End: 2026-04-30Target: 108Updated: 2026-03-13